Cargando…

Impact of hepatitis C status on 20-year mortality of patients with substance use disorders

BACKGROUND: The magnitude of the effect of hepatitis C viral infection on survival is still not fully understood. The objective of this study was to determine whether the presence of hepatitis C viral antibodies in 1991 was associated with increased mortality 20 years later within a cohort of patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Accurso, Anthony J., Rastegar, Darius A., Ghazarian, Sharon R., Fingerhood, Michael I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672505/ https://www.ncbi.nlm.nih.gov/pubmed/26463043 http://dx.doi.org/10.1186/s13722-015-0041-6

Ejemplares similares

Immigration Status and Substance Use Disorder-related Mortality in Sweden: A National Longitudinal Registry Study
por: Lundgren, Lena, et al.
Publicado: (2019)

Continuum of hepatitis C care in France: A 20-year cohort study
por: Hermetet, Coralie, et al.
Publicado: (2017)

Substance use disorders and avoidable mortality after prison
por: Wakeman, Sarah E, et al.
Publicado: (2015)

Morbidity and mortality in schizophrenia with comorbid substance use disorders
por: Lähteenvuo, Markku, et al.
Publicado: (2021)

Multidisciplinary and Integrated Treatment for Substance Use Disorders and Hepatitis C in an Addiction Treatment Service in India
por: Ghosh, Abhishek, et al.
Publicado: (2022)

Parenteral Pethidine for labour pain relief and substance use disorder: 20-year follow-up cohort study in offspring
por: Pereira, Robert Rodrigues, et al.
Publicado: (2012)

The impact of hepatitis C viremia status on lung functions in chronic hepatitis c patients
por: Bal, Tayibe, et al.
Publicado: (2019)

Mental disorders and total mortality after 20 years in an adult general population sample
por: John, Ulrich, et al.
Publicado: (2020)

Chronic pain and substance use in patients with Hepatitis C
por: Morasco, Ben
Publicado: (2010)

Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services
por: Frimpong, Jemima A., et al.
Publicado: (2016)

Hepatitis C virus cascade of care in the general population, in people with diabetes, and in substance use disorder patients
por: Djuric, Olivera, et al.
Publicado: (2021)

Longitudinal Analysis of Substance Use Disorder Symptom Severity at Age 18 Years and Substance Use Disorder in Adulthood
por: McCabe, Sean Esteban, et al.
Publicado: (2022)

Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life
por: Cuomo, Ilaria, et al.
Publicado: (2018)

Providing Hepatitis C Treatment Locally for Substance-Using Patients
por: Clapp, Susan B., et al.
Publicado: (2023)

Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders
por: Huckans, Marilyn S, et al.
Publicado: (2007)

Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management
por: Grau-López, Lara, et al.
Publicado: (2021)

The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders
por: Jiang, Xinyi, et al.
Publicado: (2021)

Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States
por: Park, Haesuk, et al.
Publicado: (2023)

Postpartum Hepatitis C Linkage to Care Program in a Co-located Substance Use Disorders Treatment Model
por: Cheedalla, Aneesha, et al.
Publicado: (2023)

Morbidity and mortality in schizophrenia with comorbid substance use disorders in Finland and Sweden
por: Lähteenvuo, M., et al.
Publicado: (2021)

One-year mortality of emergency department patients with substance-induced psychosis
por: Barbic, David, et al.
Publicado: (2022)

The impact of psychiatric disorders of parents on the severity of substance use disorder in their offspring
por: El-Makawi, S., et al.
Publicado: (2022)

Results of a Hepatitis C Micro-Elimination Program in Two Addiction Centers Among Subjects With Substance Use Disorder
por: Vega-Astudillo, Pablo, et al.
Publicado: (2022)

Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C
por: Jiang, Xinyi, et al.
Publicado: (2021)

All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
por: Roelens, Maroussia, et al.
Publicado: (2020)

Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Trends in cause-specific mortality in HIV–hepatitis C coinfection following hepatitis C treatment scale-up
por: Kronfli, Nadine, et al.
Publicado: (2019)

Trends in mortality and life expectancy in Fiji over 20 years
por: Dearie, Catherine, et al.
Publicado: (2021)

The Ventral Tegmental Area and Nucleus Accumbens as Circadian Oscillators: Implications for Drug Abuse and Substance Use Disorders
por: Becker-Krail, Darius D., et al.
Publicado: (2022)

Integrated Models of Care for People Living with Hepatitis C Virus and a Substance Use Disorder: Protocol for a Systematic Review
por: Ti, Lianping, et al.
Publicado: (2018)

Impact of parental history of substance use disorders on the clinical course of anxiety disorders
por: Pagano, Maria E, et al.
Publicado: (2007)

Impact on mortality of being seropositive for hepatitis C virus antibodies among blood donors in Brazil: A twenty-year study
por: Filho, Hélio Ranes de Menezes, et al.
Publicado: (2019)

386 Hypersensitivity Reactions to Interferon Based Treatment for Hepatitis C: A Single Center 20-Year Experience
por: Sidiropoulos, Ioannis, et al.
Publicado: (2012)

Incidence of Hepatitis C Infection among Prisoners by Routine Laboratory Values during a 20-Year Period
por: Marco, Andrés, et al.
Publicado: (2014)

New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
por: Dennis, Brittany B, et al.
Publicado: (2021)

Substance use and substance use disorders in Africa: An epidemiological approach to the review of existing literature
por: Onaolapo, Olakunle James, et al.
Publicado: (2022)

Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments
por: Melamed, Osnat C., et al.
Publicado: (2022)

Impact of Continuing Care on Recovery From Substance Use Disorder
por: McKay, James R.
Publicado: (2021)

Mortality, cause of death and risk factors in patients with alcohol use disorder alone or poly-substance use disorders: a 19-year prospective cohort study
por: Hjemsæter, Arne Jan, et al.
Publicado: (2019)

Mortality rate trends in patients diagnosed with schizophrenia or bipolar disorder: a nationwide study with 20 years of follow-up
por: Lomholt, Line Hosbond, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g65q1paj5vjh5bim9gr5j9dkjp